Conjugate pneumococcal vaccines for non-indigenous children in Australia

Medical Journal of Australia

Volumn 173, Issue SUPPL. OCT., 2000, Pages

  McIntyre, P B ^a   Nolan, T M ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; AUSTRALIA; CHILD; COST EFFECTIVENESS ANALYSIS; FEMALE; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; PROTEIN PROTEIN INTERACTION; REVIEW; SEROTYPE; STREPTOCOCCUS INFECTION; VACCINATION;

EID: 0034596985     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2000.tb139417.x     Document Type: Review

References (34)

1. Food and drug administration
2. Immunogenicity of pneumococcal conjugate vaccines
3. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group
4. Invasive Haemophilus influenzae type b disease in Sydney children - A population-based study
5. Worldwide epidemiology of invasive Haemophilus influenzae type b disease
6. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants
7. Streptococcus pneumoniae
8. Invasive pneumococcal infections: Incidence, predisposing factors, and prognosis
9. Epidemiology of invasive pneumococcal infections in children in Finland
10. Pneumococcal bacteremia in Monroe County, New York
11. Pneumococcal bacteremia in Charleston County, South Carolina. A decade later
12. Epidemiology of invasive childhood pneumococcal infections in Israel
13. Invasive pneumococcal disease in a paediatric population, Auckland, New Zealand
14. Epidemiology of invasive pneumococcal disease in Victoria, Australia
15. Incidence of invasive pneumococcal disease in Sydney children, 1991-96
16. Epidemiology of invasive pneumococcal disease in urban New South Wales, 1997-1999
17. Epidemiology of invasive pneumococcal disease in southern California: Implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial
18. Paediatric invasive pneumococcal disease in Switzerland
19. Invasive pneumococcal infection in South and West England
20. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998
21. Hospital admissions in children due to pneumococcal pneumonia in England
22. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children
23. Seroepidemiology of invasive pneumococcal disease in Queensland, 1990-97
24. Invasive pneumococcal disease in the population of Victoria
25. The Vaccine Impact Surveillance Network - Invasive Pneumococcal Study Group. Are current recommendations for pneumococcal vaccination appropriate for Western Australia?
26. The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use, part II
27. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
28. The impact of Hib conjugate vaccines in preventing invasive H. influenzae diseases in the UK
29. A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children
30. Childhood immunisation 2000
31. Bacterial vaccines and serotype replacement: Lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae